Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Fermenta Biotec has informed that the Company, through its officials, will be participating in One-to-one meeting with investors on December 15, 2025 in Mumbai. The company has further informed that the Press Release dated November 11, 2025 regarding unaudited financial results for the half year ended September 30, 2025 and relevant Investor Presentation to be discussed with investors in the above interactions have been uploaded on the website of the Company - www.fermentabiotech.com and it is also available on BSE’s website: www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: